7-Quinolinamine,8-methyl-(9CI)(116632-62-3)
- Name: 7-Quinolinamine,8-methyl-(9CI)
- Synonyms:7-Amino-8-methylquinoline
- Molecular Formula:C10H10 N2
- Molecular Weight:158.203
- CAS Registry Number:116632-62-3
- EINECS:
- Melting Point:134-136℃
- Water Solubility:
CAS No.116632-62-3 7-Quinolinamine,8-methyl-(9CI)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.116632-62-3 7-Amino-8-methylquinoline
Assay:98%Min Appearance:detailed in specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by ocean shipping Application:An important raw material and intermediate used in Organic Synthesis, Pharmaceuticals
Min. Order:0
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)]
CAS No.116632-62-3 7-Quinolinamine,8-methyl-
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)]
CAS No.116632-62-3 7-Quinolinamine,8-methyl-(9CI)
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:7-Quinolinamine,8-methyl-(9CI)
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
CAS No.116632-62-3 7-Quinolinamine,8-methyl-(9CI)
Assay:99% Appearance:white powder Package:25kg,50kg,180kg,200kg,250kg,1000kg锛宑ustomization Storage:Keep it in dry,shady and cool place Transportation:by express or by sea Application:Pharma;Industry;Agricultural;chemical reaserch
Min. Order:0
Supplier:Wuhan Circle Star Chem-medical Technology co.,Ltd. [
China (Mainland)]

Other Product
- 116673-47-3/(+/-) CIS-2,5-BIS(3,4,5-TRIMETHOXYPHENYL)-1,3-DIOXOLANE
- 116668-39-4/[1,1-Biphenyl]-3,3-diol,6,6-dimethyl-(9CI)
- 116661-86-0/N-BOC-(2R,3R)-2-HYDROXY-3-AMINO-4-PHENYLBUTANOIC ACID
- 116660-75-4/2-Pentanone, 4-hydroxy-3-methyl-, [S-(R*,S*)]- (9CI)
- 116660-69-6/Bicyclo[3.1.0]hexan-3-one, 4-methylene-1-(1-methylethyl)-, (1R)- (9CI)
- 116660-68-5/Bicyclo[3.1.0]hexan-3-one, 4-methylene-1-(1-methylethyl)- (9CI)
- 116655-28-8/4-Pyridazinecarboxamide,2,5-dihydro-2-methyl-(9CI)
- 116653-28-2/BUSULFAN-D8 (TETRAMETHYLENE-D8)
- 116652-74-5/1H-Benzimidazole,1-ethenyl-5,6-dimethyl-(9CI)
- 116643-17-5/2H-Benzimidazole-2-thione,1,3-dihydro-4,5-dimethyl-(9CI)
- 116642-98-9/BIS(2 6-DIPHENYLPHENOXY)NIOBIUM(V)
- 116638-33-6/Blood-coagulationfactor LACI (human clone lP9 precursor protein moiety reduced) (9CI)
- 116636-52-3/2-Thiazolecarbamic acid, 5-thiocyanato-, ethyl ester (6CI)
- 116633-53-5/bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate
- 116633-22-8/Ethanone, 2-bromo-1-(1-hydroxycyclopentyl)- (9CI)
- 116632-62-3/7-Quinolinamine,8-methyl-(9CI)
- 116547-91-2/N-(2-Bromophenyl)methansulfonamide
- 116412-77-2/1,5-DICHLORO-2,4-BIS-TRIFLUOROMETHYL-BENZENE
- 116378-72-4/1H-Pyrazolo[3,4-g]quinoxaline (9CI)
- 116378-71-3/Isoxazolo[4,5-g]quinoxaline (9CI)
- 116376-29-5/2-[2-(BENZYLOXY)ETHYL]-5,5-DIMETHYL-1,3-DIOXANE
- 116374-21-1/PHOSPHORIC ACID-17O4
- 116373-84-3/Ethanone, 2-chloro-1-(octahydro-6-hydroxy-1H-inden-1-yl)- (9CI)
- 116373-71-8/m-Dioxane, 2-propenyl-4-isopropyl-5,5-dimethyl-
- 116373-36-5/4-ISOPROPYLCINNAMIC ACID
- 116373-17-2/Cyclohexanone, 2-(1-butynyl)- (9CI)
- 116371-67-6/2'-Deoxy-2',2'-difluoro-5'-cytidylic Acid
- 116369-23-4/2-fluoro-3-trifluoromethoxy aniline